Intro -- Acknowledgements -- Abbreviations -- Glossary -- Navigation diagram -- Colour codes for diseases -- Executive summary -- I. Background -- I.I. Sustainable development goals (SDG) -- I.III WHO Global NCD Action Plan -- Cardiovascular diseases: global situation -- Stroke: global situation -- Diabetes: global situation -- I.IV Availability of and access to medical devices for NCDs -- II. Methodology -- II.I Search and selection of clinical guidelines -- II.II Selected clinical guidelines -- Cardiovascular diseases (except stroke) -- Stroke -- Diabetes -- II.III Additional clinical guidelines -- II.IV Relevant WHO publications -- II.V Selection of the clinical interventions -- III. Priority medical devices by clinical area -- III.I Priority intervention lists -- III.II Introduction to listing of priority medical devices for cardiovascular diseases and diabetes -- Levels of health care -- Types of medical devices, according to use -- 1. Clinical Assessment -- 1.1 General priority medical devices for clinical assessment interventions -- 1.2 Specific priority medical devices for clinical assessment interventions, by disease -- 1.2.1 Cardiovascular diseases -- 1.2.2 Stroke -- 1.2.3 Diabetes -- 2. Emergency care -- 2.1 General priority medical devices for emergency care -- 3. Clinical laboratory -- 3.1 General priority medical devices for clinical laboratory interventions -- 3.2 Specific priority medical devices for clinical laboratory interventions, by disease -- 3.2.1 Cardiovascular diseases -- 3.2.2 Stroke -- 3.2.3 Diabetes -- 4. Other specialized diagnostics -- 4.1 Specific priority medical devices for clinical assessment interventions by disease -- 4.1.1 Cardiovascular diseases -- 4.1.2 Stroke -- 4.1.3 Diabetes -- 5. Medical imaging -- 5.1 General priority medical devices for medical imaging interventions.

5.2 Specific priority medical devices for imaging interventions, by disease -- 5.2.1 Cardiovascular diseases -- 5.2.2 Stroke -- 5.2.3 Diabetes -- 6. Surgery -- 6.1 General priority medical devices for surgical interventions -- 6.2 Specific priority medical devices for surgical interventions, by disease -- 6.2.1 Cardiovascular diseases -- 6.2.2 Stroke -- 6.2.3 Diabetes -- 7. Non-surgical interventions -- 7.1 Specific priority medical devices for non-surgical interventions, by disease -- 7.1.1 Stroke -- 7.1.2 Diabetes -- 8. Hospitalization -- 8.1 General priority medical devices for hospitalization interventions -- 8.2 Specific priority medical devices for hospitalization interventions, by disease -- 8.2.1 Cardiovascular diseases -- 8.2.2 Stroke -- 8.2.3 Diabetes -- 9. Intensive care units -- 9.1 General priority medical devices for the intensive care unit -- 9.2 Specific priority medical devices for monitoring and intensive care unit, by disease -- 9.2.1 Cardiovascular diseases -- 9.2.2 Stroke -- 9.2.3 Diabetes -- 10. Rehabilitation -- 10.1 General assistive products for rehabilitation -- 10.2.1 Specific assistive products for rehabilitation in people with heart disease -- 10.2.2 Specific assistive products for rehabilitation in people with stroke disease -- 10.2.3 Specific assistive products for rehabilitation in people with lower limb amputation due to complication of diabetes. -- 11. Palliative care -- 11.1 General priority medical devices for palliative care -- IV. Implementation strategy -- IV.I Needs assessment for policy and strategy development -- V Concluding remarks -- References -- Annex 1. Expert information -- Annex 2. Search terms for clinical guidelines by Cochrane Netherland -- Annex 3. Shortened version of the NEATS instrument (built on the framework of the AGREE II tool) -- Annex 4. Explanations concerning medical devices.

Annex 5. Instrument kits and sets.